Advanced Biomed Inc (ADVB)
Advanced Biomed Inc. engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment, offering devices and assay products such as automated sample preparation systems, rare cell detection devices, and immunochromogenic kits to identify various circulating tumor cells and tumor-associated macrophages. The company is also developing early lung cancer screening technology and operates medical clinics in China.
Company Info
Highlights
-$844.47K
$0.56 - $4.10
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Advanced Biomed Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading data...
Returns By Period
ADVB
- YTD
- N/A
- 1M
- -11.35%
- 6M
- N/A
- 1Y
- N/A
- 3Y*
- N/A
- 5Y*
- N/A
- 10Y*
- N/A
^GSPC (Benchmark)
- YTD
- 7.06%
- 1M
- 5.28%
- 6M
- 5.00%
- 1Y
- 14.38%
- 3Y*
- 16.95%
- 5Y*
- 14.32%
- 10Y*
- 11.51%
Monthly Returns
The table below presents the monthly returns of ADVB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Based on daily data since Mar 2025, the average daily return (also called the expected return) is -1.44%, while the average monthly return is -24.78%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 7.40% | -50.99% | -46.38% | -32.04% | -4.14% | -81.62% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Advanced Biomed Inc (ADVB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Advanced Biomed Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Advanced Biomed Inc was 84.10%, occurring on Jun 26, 2025. The portfolio has not yet recovered.
The current Advanced Biomed Inc drawdown is 82.83%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -84.1% | Mar 31, 2025 | 61 | Jun 26, 2025 | — | — | — |
| -7.11% | Mar 12, 2025 | 2 | Mar 13, 2025 | 2 | Mar 17, 2025 | 4 |
| -6.17% | Mar 18, 2025 | 1 | Mar 18, 2025 | 4 | Mar 24, 2025 | 5 |
| -3.73% | Mar 10, 2025 | 1 | Mar 10, 2025 | 1 | Mar 11, 2025 | 2 |
| -0.26% | Mar 25, 2025 | 1 | Mar 25, 2025 | 1 | Mar 26, 2025 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Advanced Biomed Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Advanced Biomed Inc, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Advanced Biomed Inc is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ADVB relative to other companies in the Diagnostics & Research industry. Currently, ADVB has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ADVB in comparison with other companies in the Diagnostics & Research industry. Currently, ADVB has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |